Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 2,514 | 3,299 | 7,699 | 5,747 | 4,741 |
| Operating Income | -2,514 | -3,299 | -7,699 | -5,747 | -4,741 |
| Other Income | -53 | -42 | -52 | -65 | -63 |
| Pre-tax Income | -2,567 | -3,341 | -7,751 | -5,812 | -4,804 |
| Net Income Continuous | -2,567 | -3,341 | -7,751 | -5,812 | -4,804 |
| Net Income | $-2,567 | $-3,341 | $-7,751 | $-5,812 | $-4,804 |
| EPS Basic Total Ops | -4.25 | -5.50 | -13.50 | -10.75 | -9.00 |
| EPS Basic Continuous Ops | -4.35 | -5.50 | -13.61 | -10.68 | -9.06 |
| EPS Diluted Total Ops | -4.25 | -5.50 | -13.50 | -10.75 | -9.00 |
| EPS Diluted Continuous Ops | -4.35 | -5.50 | -13.61 | -10.68 | -9.06 |
| EBITDA(a) | $-2,514 | $-3,299 | $-7,690 | $-5,734 | $-4,727 |